Marcia Roxana Cruz-Correa, Sae-Won Han, Rozita Abdul Malik, Harvey Yu-Li Su, Marc Van Den Eynde, Paul Eliezer Oberstein, Ying Yuan, Víctor Moreno, Filippo Pietrantonio, Eric Xueyu Chen, Kanwal Pratap Singh Raghav, Sanjib Chowdhury, Xuesong Lu, Rianka Bhattacharya, Praveen Barala, Cecilia Monge, Seema Niphadkar Sethi, Sreenivasa R. Chandana. "Antitumor activity of amivantamab by consensus molecular subtypes in
                    <i>RAS</i>
                    /
                    <i>BRAF</i>
                    wild-type metastatic colorectal cancer: Secondary analyses from the phase 1b/2 OrigAMI-1 study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3548